Marimed (MRMD) Operating Expenses (2011 - 2026)

Marimed (MRMD) has reported Operating Expenses for 16 consecutive years, with $15.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Operating Expenses rose 6.01% year-over-year to $15.8 million in Q2 2026; TTM through Jun 2026 was $60.7 million, a 0.46% change from a year earlier, with the FY2025 full-year figure at $60.7 million, up 1.16% from the prior year.
• Operating Expenses was $15.8 million for Q2 2026 at Marimed, up from $15.2 million in the prior quarter.
• Over five years, Operating Expenses peaked at $16.0 million in Q1 2025 and troughed at $9.9 million in Q1 2022.
• A 5-year average of $13.7 million and a median of $14.6 million in 2024 frame the typical range for Operating Expenses.
• The widest YoY moves for Operating Expenses: up 61.47% in 2022, down 10.95% in 2022.
• Over 5 years, Operating Expenses stood at $12.7 million in 2022, then rose by 17.16% to $14.9 million in 2023, then decreased by 5.25% to $14.1 million in 2024, then climbed by 6.39% to $15.0 million in 2025, then advanced by 5.19% to $15.8 million in 2026.
• The last three Operating Expenses figures came in at $15.8 million (Q2 2026), $15.2 million (Q1 2026), and $15.0 million (Q4 2025), per Business Quant data.